Back to search
Rifampicin-Resistant Pulmonary Tuberculosis Patients
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Rifampicin-Resistant Pulmonary Tuberculosis Patients trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Rifampicin-Resistant Pulmonary Tuberculosis Patients trials you may qualify forThis is a multicenter, randomized, open-label, active-controlled clinical study designed to evaluate the efficacy, safety, and pharmacokinetic characteristics o…
This is a multicenter, randomized, double-blind, active-controlled Phase III study to evaluate the efficacy and safety of Sudapyridine (WX-081) combined with a…
Tuberculosis increases energy demands and protein breakdown, leading to muscle wasting. Malnutrition and minimal weight gain less than 5% in first two months pr…
The goal of this clinical trial is to learn how Sudapyridine (WX-081) tablets interact with other drugs and how food intake affects its pharmacokinetics in heal…